Summary of opinion: Hetronifly, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Summary of opinion: Hetronifly, 21/05/2026 Positive
Summary of opinion: Enhertu, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Summary of opinion: Enhertu, 21/05/2026 Positive
Summary of opinion: Fasenra, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Summary of opinion: Fasenra, 21/05/2026 Positive
Summary of opinion: Keytruda, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Summary of opinion: Keytruda, 21/05/2026 Positive
Summary of opinion: Padcev, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Summary of opinion: Padcev, 21/05/2026 Positive
Human medicines European public assessment report (EPAR): Vijoice, alpelisib, Status: Opinion
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Human medicines European public assessment report (EPAR): Vijoice, alpelisib, Status: Opinion
Summary of opinion: Keytruda, 21/05/2026 Positive
Submitted by Anonymous (not verified) on 22 May 2026 - 11:00
Summary of opinion: Keytruda, 21/05/2026 Positive
Hantavirus
Submitted by Anonymous (not verified) on 22 May 2026 - 10:20
Hantavirus
PSUSA/00003006/202503
Submitted by Anonymous (not verified) on 22 May 2026 - 9:23
PSUSA/00003006/202503
Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised
Submitted by Anonymous (not verified) on 21 May 2026 - 14:40
Human medicines European public assessment report (EPAR): Nuwiq, simoctocog alfa, Date of authorisation: 22/07/2014, Revision: 14, Status: Authorised